A mouse model for chronic intermittent electronic cigarette exposure exhibits nicotine pharmacokinetics resembling human vapers
Authors:
- 1 October 2019
- journal article
- research article
- Published by Elsevier in Journal of Neuroscience Methods
- Vol. 326, 108376
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- National Institute on Drug Abuse
- Tobacco-Related Disease Research Program
- National Heart, Lung, and Blood Institute
- National Institute on Minority Health and Health Disparities
This publication has 48 references indexed in Scilit:
- Levels of selected carcinogens and toxicants in vapour from electronic cigarettesTobacco Control, 2013
- Acute impact of active and passive electronic cigarette smoking on serum cotinine and lung functionInhalation Toxicology, 2013
- Electronic Cigarettes: Effective Nicotine Delivery After Acute AdministrationNicotine & Tobacco Research, 2012
- Effect of nicotine on body composition in miceJournal of Endocrinology, 2011
- Dopamine in Motivational Control: Rewarding, Aversive, and AlertingNeuron, 2010
- Exposure to chronic intermittent nicotine vapor induces nicotine dependencePharmacology Biochemistry and Behavior, 2010
- Role of CYP2A5 in the Clearance of Nicotine and Cotinine: Insights from Studies on a Cyp2a5-null Mouse ModelThe Journal of Pharmacology and Experimental Therapeutics, 2010
- A Comparison of Mainstream and Sidestream Marijuana and Tobacco Cigarette Smoke Produced under Two Machine Smoking ConditionsChemical Research in Toxicology, 2007
- Circadian Pharmacokinetics of Mycophenolic Acid and Implication of Genetic Polymorphisms for Early Clinical Events in Renal Transplant RecipientsTransplantation, 2006
- Metabolism and Disposition Kinetics of NicotinePharmacological Reviews, 2005